This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/domain/vavai/projekt/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n16http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00027162%3A_____%2F07%3A%230000169%21RIV08-GA0-00027162/
n12http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n4http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00027162%3A_____%2F07%3A%230000169%21RIV08-GA0-00027162
rdf:type
skos:Concept n12:Vysledek
dcterms:description
A panel of 380 commercially available monoclonal antibodies (mAbs) against human CD molecules was tested for cross-reactivity on canine peripheral blood leukocytes, platelets and erythrocytes by flow cytometry. This testing resulted in 51 cross-reacting mAbs. mAbs with specificity for CD9, CD29, CD42a, CD61, and CD41/CD61 showed cross-reactivity with canine platelets and one mAb with the erythrocyte antigen CD235a. Canine leukocyte-reactive mAbs included those with specificity for CD11a, CD11b, CD14, CD18, CD21, CD22, CD47, CD49d, CD49e, CD56, CD62L, CD91, CD94, and CD172a. In addition, several mAbs resulted in a staining pattern of canine cells which suggest that the canine epitope equivalents have an alternate expression pattern from that expected for humans (CD1a, CD35, CD44, CD45, CD75s, CD81). In summary, this study confirmed the reactivity of previously described crossreactive mAbs with canine cells and resulted in the characterization of mAbs recognizing so far undetectable canine CD molecules. A panel of 380 commercially available monoclonal antibodies (mAbs) against human CD molecules was tested for cross-reactivity on canine peripheral blood leukocytes, platelets and erythrocytes by flow cytometry. This testing resulted in 51 cross-reacting mAbs. mAbs with specificity for CD9, CD29, CD42a, CD61, and CD41/CD61 showed cross-reactivity with canine platelets and one mAb with the erythrocyte antigen CD235a. Canine leukocyte-reactive mAbs included those with specificity for CD11a, CD11b, CD14, CD18, CD21, CD22, CD47, CD49d, CD49e, CD56, CD62L, CD91, CD94, and CD172a. In addition, several mAbs resulted in a staining pattern of canine cells which suggest that the canine epitope equivalents have an alternate expression pattern from that expected for humans (CD1a, CD35, CD44, CD45, CD75s, CD81). In summary, this study confirmed the reactivity of previously described crossreactive mAbs with canine cells and resulted in the characterization of mAbs recognizing so far undetectable canine CD molecules. 380 komerčně dostupných monoklonálních protilátek (mAbs) proti lidským CD molekulám bylo testováno na křížovou reaktivitu na leukocytech, trombocytech a erytrocytech periferní krve psa pomocí průtokové cytometrie. Bylo nalezeno celkem 51 křížově reagujících mAbs. mAbs se specificitou pro CD9, CD29, CD42a, CD61 a CD41/CD61 vykazovaly reaktivitu s psími trombocyty a jedna mAb reagovala s erytrocytárním antigenem CD235a. S leukocyty psa reagovalo několik mAbs se specificitou pro CD11a, CD11b, CD14, CD18, CD21, CD22, CD47, CD49d, CD49e, CD56, CD62L, CD91, CD94 a CD172a. Navíc, několik mAbs vykazovalo charakter značení, který naznačuje, že psí ekvivalenty mají jinou buněčnou expresi než jaká se dala očekávat z údajů z lidské imunologie. Mezi tyto mAbs patří protilátky proti CD1a, CD35, CD44, CD45, CD75s, CD81. Výsledkem práce tedy je, že byla potvrzena křížová reaktivita některých již dříve popsaných protilátek a byly charakterizovány mAbs, které rozpoznávají dosud nedetekované CD molekuly psa.
dcterms:title
Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes Reaktivita křížově reagujících monoklonálních protilátek s leukocyty, trombocyty a erytrocyty psa Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes
skos:prefLabel
Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes Reaktivita křížově reagujících monoklonálních protilátek s leukocyty, trombocyty a erytrocyty psa Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes
skos:notation
RIV/00027162:_____/07:#0000169!RIV08-GA0-00027162
n3:strany
47;55
n3:aktivita
n14:P
n3:aktivity
P(GP524/02/P010)
n3:cisloPeriodika
1-2
n3:dodaniDat
n4:2008
n3:domaciTvurceVysledku
n6:7153643
n3:druhVysledku
n15:J
n3:duvernostUdaju
n17:S
n3:entitaPredkladatele
n16:predkladatel
n3:idSjednocenehoVysledku
446496
n3:idVysledku
RIV/00027162:_____/07:#0000169
n3:jazykVysledku
n11:eng
n3:klicovaSlova
Dogs; Monoclonal antibodies; Cross-reactivity; Flow cytometry
n3:klicoveSlovo
n9:Monoclonal%20antibodies n9:Dogs n9:Flow%20cytometry n9:Cross-reactivity
n3:kodStatuVydavatele
NL - Nizozemsko
n3:kontrolniKodProRIV
[4243A4E8EBE8]
n3:nazevZdroje
Veterinary Immunology and Immunopathology
n3:obor
n10:GJ
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
4
n3:projekt
n13:GP524%2F02%2FP010
n3:rokUplatneniVysledku
n4:2007
n3:svazekPeriodika
119
n3:tvurceVysledku
Faldyna, Martin
s:issn
0165-2427
s:numberOfPages
9